"That's particularly encouraging, because these drugs, now used to treat hepatitis C, are widely available, says Anthony Fauci, director of the infectious-disease institute, which financed the research."
"That's particularly encouraging, because these drugs, now used to treat hepatitis C, are widely available, says Anthony Fauci, director of the infectious-disease institute, which financed the research."